Two Sigma Advisers’s Pliant Therapeutics PLRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,245,600	Closed	-$1.52M	–	1585
2025 Q4	$1.52M	Buy	1,245,600 +173,100	+16%	+$260K	﹤0.01%	1292
2025 Q3	$1.59M	Buy	1,072,500 +617,300	+136%	+$942K	﹤0.01%	1240
2025 Q2	$528K	Buy	455,200 +113,000	+33%	+$160K	﹤0.01%	1725
2025 Q1	$462K	Buy	342,200 +206,500	+152%	+$1.25M	﹤0.01%	1815
2024 Q4	$1.79M	Sell	135,700 -22,100	-14%	-$302K	﹤0.01%	1170
2024 Q3	$1.77M	Sell	157,800 -31,900	-17%	-$399K	﹤0.01%	1137
2024 Q2	$2.04M	Buy	189,700 +40,200	+27%	+$518K	﹤0.01%	1181
2024 Q1	$2.23M	Buy	149,500 +56,900	+61%	+$939K	0.01%	1165
2023 Q4	$1.68M	Sell	92,600 -68,800	-43%	-$1.05M	﹤0.01%	1386
2023 Q3	$2.8M	Sell	161,400 -34,100	-17%	-$591K	0.01%	1016
2023 Q2	$3.54M	Sell	195,500 -72,800	-27%	-$1.72M	0.01%	919
2023 Q1	$7.14M	Buy	268,300 +91,100	+51%	+$2.59M	0.02%	666
2022 Q4	$3.43M	Buy	177,200 +76,600	+76%	+$1.6M	0.01%	947
2022 Q3	$2.1M	Buy	100,600 +45,400	+82%	+$869K	0.01%	1149
2022 Q2	$442K	Sell	55,200 -21,900	-28%	-$140K	﹤0.01%	1977
2022 Q1	$540K	Buy	77,100 +31,700	+70%	+$323K	﹤0.01%	1952
2021 Q4	$613K	Buy	+45,400	New	+$722K	﹤0.01%	1816